John Anderson, MD, is medical advisor of the Diabetes Leadership Council in Nashville. Our neighbors are concerned about facing rising costs of health care, and rightfully so. For insulin, the ...

Former MD Anderson Cancer Center President Dr. John Mendelsohn, battling brain cancer, is retiring after 22 years at the elite Houston research hospital. Mendelsohn, 81, will become president ...

Anesthesiologist John Anderson, MD, died at age 91 on Nov. 21 in Cleveland, according to an obituary published by WMFD.com Nov. 22. He worked in private practice at St. Anthony Hospital in Columbus, ...

John Anderson, MD: There are a lot of factors to consider when you’re looking at trying to choose the right medication for a patient. We always go back to diet and exercise.

John Anderson, MD: In June of 2017 in San Diego, at the American Diabetes Association Scientific Sessions, the CANVAS trial results were released. Again, this was the second SGLT2 inhibitor to be ...

John Anderson, MD: In Stockholm in September of 2015, there had been an announcement that, for the very first time, there was actually a cardiovascular benefit with one of the SGLT2 inhibitors.